Emergence of a BCR::ABL1 rearrangement following a uniquely complex clonal evolution pattern in a patient undergoing Fms‐like tyrosine kinase 3 inhibitor therapy for acute myeloid leukemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of laboratory hematology 2023-04, Vol.45 (2), p.e24-e27
Hauptverfasser:	Park, Bosung, Kim, Jiyeon, Kim, Miyoung, Cho, Young‐Uk, Hwang, Sang‐Hyun, Jang, Seongsoo, Seo, Eul‐Ju, Choi, Eun‐Ji, Park, Chan‐Jeoung
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute myeloid leukemia Antineoplastic Agents - therapeutic use Clonal Evolution - genetics Drug Resistance, Neoplasm fms-Like Tyrosine Kinase 3 - antagonists & inhibitors Fusion Proteins, bcr-abl - genetics Humans Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - genetics Protein Kinase Inhibitors - therapeutic use Protein-tyrosine kinase
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!